1Senior Lecturer, Department of Periodontics and OralImplantology, Institute of Dental Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India
2Professor & Head, Department of Periodontics and OralImplantology, Institute of Dental Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India
3Professor, Department of Periodontics and OralImplantology, Institute of Dental Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India
*Corresponding Author: Dr. Gatha Mohanty, Senior Lecturer, Department of Periodontics and OralImplantology, Institute of Dental Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India, e-mail: gathamohanty@soa.ac.in
Online published on 27 March, 2020.
Chronic usage of anti-hypertensive, immunosuppressants could result in unwanted effect such as gingival overgrowth. The severity and expression of this tissue specific condition could be also be influenced microbial plaque. Increase in volume of gingiva compromises the esthetics, speech and acts as a hindrance for maintenance of optimal oral hygiene. The management of such cases needs a combination of non surgical and surgical approach. This case report highlights the successful management of drug induced gingival overgrowth by a combined non-surgical and surgical approach. It also focuses on the role of supportive periodontal therapy during 1 year follow-up.
Cyclosporin A, gingival overgrowth, gingivectomy, immunosuppresant
